BRD-K98645985 is a BAF (mammalian SWI/SNF) transcriptional repression inhibitor with an EC 50 of ~2.37 µM. BRD-K98645985 binds ARID1A-specific BAF complexes, prevents nucleosomal positioning, and potently reverses HIV-1 latency, without T cell activation or toxicity In Vitro BRD-K98645985 (30 µM; 18 hours) treatment shows a 5-fold increase in Bmi1 , 2.6-fold increase in Ring1 , and 3.3-fold decrease in Fgf4. BRD-K98645985 treatment shows a concentration dependent latency reversal in J-Lat T-cell line models. BRD-K98645985 can be combined with other LRAs to improve reservoir targeting. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:BAF transcriptional repression 2.37 μM (EC 50 ) HIV-1
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
BRD-K98645985
CAS number：1357647-78-9 molecular formula：C33H43N5O4
overview
compound introduction
Specs
| Chinese alias | - | ||
| English alias | - | ||
| CAS number | 1357647-78-9 | molecular formula | C33H43N5O4 |
| molecular weight | 573.73 g/mol | Exact mass | ≥99% |
| PSA | 96.000 Ų | logp | 4.200 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
